Ascendis Pharma A/S ADR (NASDAQ: ASND) on Friday, soared 4.88% from the previous trading day, before settling in for the closing price of $210.16. Within the past 52 weeks, ASND’s price has moved between $118.03 and $223.18.
Annual sales at Healthcare sector company slipped by -6.13% over the past five years. The company achieved an average annual earnings per share of 50.49%. With a float of $60.47 million, this company’s outstanding shares have now reached $61.10 million.
Ascendis Pharma A/S ADR (ASND) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Ascendis Pharma A/S ADR is 1.03%, while institutional ownership is 104.72%. The most recent insider transaction that took place on Dec 04 ’25, was worth 2,081,019. Before that another transaction happened on Dec 02 ’25, when Company’s CEO proposed sale 100,000 for $210.85, making the entire transaction worth $21,085,000.
Ascendis Pharma A/S ADR (ASND) Latest Financial update
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.64 earnings per share (EPS) for the period topping the consensus outlook (set at -0.93) by 0.29. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.41 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 50.49% per share during the next fiscal year.
Ascendis Pharma A/S ADR (NASDAQ: ASND) Trading Performance Indicators
Ascendis Pharma A/S ADR (ASND) is currently performing well based on its current performance indicators. A quick ratio of 0.73 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 18.69.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.25, a number that is poised to hit -0.11 in the next quarter and is forecasted to reach 4.37 in one year’s time.
Technical Analysis of Ascendis Pharma A/S ADR (ASND)
Ascendis Pharma A/S ADR (NASDAQ: ASND) saw its 5-day average volume 1.12 million, a positive change from its year-to-date volume of 0.5 million. As of the previous 9 days, the stock’s Stochastic %D was 60.57%.
During the past 100 days, Ascendis Pharma A/S ADR’s (ASND) raw stochastic average was set at 86.22%, which indicates a significant increase from 74.72% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 10.44 in the past 14 days, which was higher than the 7.92 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $206.22, while its 200-day Moving Average is $180.94. Nevertheless, the first resistance level for the watch stands at $231.07 in the near term. At $241.71, the stock is likely to face the second major resistance level. The third major resistance level sits at $253.49. If the price goes on to break the first support level at $208.65, it is likely to go to the next support level at $196.87. The third support level lies at $186.23 if the price breaches the second support level.
Ascendis Pharma A/S ADR (NASDAQ: ASND) Key Stats
Market capitalization of the company is 13.47 billion based on 61,695K outstanding shares. Right now, sales total 393,500 K and income totals -409,120 K. The company made 249,720 K in profit during its latest quarter, and -71,290 K in sales during its previous quarter.
